TY - JOUR
T1 - Two Cases of Advanced Gastric Cancer in the Upper Portion of the Stomach with Laparoscopic Total Gastrectomy after Neoadjuvant Chemotherapy
AU - Odagiri, Kazuki
AU - Miyazaki, Yasuhiro
AU - Takiguchi, Shuji
AU - Makino, Tomoki
AU - Takahashi, Tsuyoshi
AU - Kurokawa, Yukinori
AU - Yamasaki, Makoto
AU - Nakajima, Kiyokazu
AU - Mori, Masaki
AU - Doki, Yuichiro
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Case 1: A 55-year-old woman was diagnosed with type 3 gastric cancer(U, post, 30 mm, por, cT4aN2M0)of cStage III B. She received 3 courses of a DOS regimen, which consisted of docetaxel, oxaliplatin, and S-1, as neoadjuvant chemotherapy (NAC). She subsequently underwent curative laparoscopic total gastrectomy with D2+No.16a2lat dissection, and resection of part of the right crus of the diaphragm, which was suspected to have cancer infiltration. S-1 was started as adjuvant chemotherapy 37 days after gastrectomy. The patient is alive without recurrence 6 months after surgery. Case 2: A 59-yearold man was diagnosed with type 3 gastric cancer(UM-E, less, 80 mm, por, cT4aN2M0)cStage III B. NACwith DOS was administered. After 3 courses of NACwere completed, we performed spleen-preserving curative laparoscopic total gastrectomy with D2+No.16a2lat dissection. S-1 was started as adjuvant chemotherapy 54 days after gastrectomy. The patient is alive without recurrence 6 months after surgery.
AB - Case 1: A 55-year-old woman was diagnosed with type 3 gastric cancer(U, post, 30 mm, por, cT4aN2M0)of cStage III B. She received 3 courses of a DOS regimen, which consisted of docetaxel, oxaliplatin, and S-1, as neoadjuvant chemotherapy (NAC). She subsequently underwent curative laparoscopic total gastrectomy with D2+No.16a2lat dissection, and resection of part of the right crus of the diaphragm, which was suspected to have cancer infiltration. S-1 was started as adjuvant chemotherapy 37 days after gastrectomy. The patient is alive without recurrence 6 months after surgery. Case 2: A 59-yearold man was diagnosed with type 3 gastric cancer(UM-E, less, 80 mm, por, cT4aN2M0)cStage III B. NACwith DOS was administered. After 3 courses of NACwere completed, we performed spleen-preserving curative laparoscopic total gastrectomy with D2+No.16a2lat dissection. S-1 was started as adjuvant chemotherapy 54 days after gastrectomy. The patient is alive without recurrence 6 months after surgery.
UR - http://www.scopus.com/inward/record.url?scp=85029548692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029548692&partnerID=8YFLogxK
M3 - Article
C2 - 28133164
AN - SCOPUS:85029548692
VL - 43
SP - 1884
EP - 1886
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 12
ER -
